Molecular Imaging of Neuroinflammation in HIV.
Anna BoerwinkleBeau M AncesPublished in: Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology (2018)
The development of combined antiretroviral therapy (cART) has increased the lifespan of persons living with HIV (PLWH), with most PLWH having a normal life expectancy. While significant progress has occurred, PLWH continue to have multiple health complications, including HIV associated neurocognitive disorders (HAND). While the exact cause of HAND is not known, persistent neuroinflammation is hypothesized to be an important potential contributor. Molecular imaging using positron emission tomography (PET) can non-invasively evaluate neuroinflammation. PET radiotracers specific for increased expression of the translocator protein18kDa (TSPO) on activated microglia can detect the presence of neuroinflammation in PLWH. However, results from these studies have been inconsistent and inconclusive. Future studies are needed to address key limitations that continue to persist with these techniques before accurate conclusions can be drawn regarding the role of persistent neuroinflammation in PLWH.
Keyphrases
- antiretroviral therapy
- positron emission tomography
- lipopolysaccharide induced
- computed tomography
- lps induced
- hiv infected
- hiv positive
- traumatic brain injury
- human immunodeficiency virus
- pet imaging
- cognitive impairment
- hiv aids
- inflammatory response
- cerebral ischemia
- pet ct
- hiv infected patients
- hiv testing
- healthcare
- hepatitis c virus
- men who have sex with men
- public health
- mental health
- case control
- binding protein
- south africa
- subarachnoid hemorrhage
- amino acid
- blood brain barrier
- risk factors